3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Stomach Neoplasms
55
Pancreatic Neoplasms
14
Colorectal Neoplasms
6
Neoplasm Metastasis
5
Esophageal Squamous Cell Carcinoma
5
Esophageal Neoplasms
4
Biliary Tract Neoplasms
4
Advanced Pancreatic Cancer
3
Stage IV Gastric Cancer With Metastasis
2
Recurrence
2
Rectal Neoplasms
2
Locally Advanced Pancreatic Cancer
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Gastric Cancer
2
mCRC
1
Surgically-Created Resection Cavity
1
Radiation Injuries
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Non-small Cell Lung Cancer Stage â…¡
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Metastatic Gastric Adenocarcinoma
1
Lung Neoplasms
1
HER2-positive
1
HER-2 Negatived Gastric Cancer
1
Gastric Cancer With Positive Exfoliative Cancer Cells
1
Interventions
Cisplatin
38
Carboplatin
28
Gemcitabine
23
Docetaxel
20
Radiotherapy
18
Etoposide
15
Paclitaxel
13
Erlotinib Hydrochloride
13
Vinorelbine
11
Drug Therapy
11
pembrolizumab
9
aumolertinib
9
apatinib
9
Pemetrexed
9
Gefitinib
9
osimertinib
7
endostar protein
7
Thoracic Surgery, Video-Assisted
7
Blood Specimen Collection
7
camrelizumab
6
anlotinib
6
Vinblastine
6
Surgical Procedures, Operative
6
sintilimab
5
Radiosurgery
5
Fluorodeoxyglucose F18
5
Cyclophosphamide
5
Bevacizumab
5
durvalumab
4
Mitomycin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lung Neoplasms
×
S 1 (combination)
×
Clear all
NCT04274270
2020-03-19
SBRTLCES
Peking University Third Hospital
Phase NA
Unknown
60 enrolled